![](/img/cover-not-exists.png)
144TiPCheckMate 227: A randomized, open-label phase 3 trial of nivolumab, nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC)
Paz-Ares, L., Brahmer, J., Hellmann, M.D., Reck, M., O'Byrne, K., Borghaei, H., Geese, W.J., Lu, H., Nathan, F.E., Ramalingam, S.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.064
Date:
April, 2017
File:
PDF, 63 KB
english, 2017